ConductScience.org, home

Paper41548

The effects of repeated nocturnal doses of clobazam, dipotassium chlorazepate and placebo on subjective ratings of sleep and early morning behaviour and objective measures of arousal, psychomotor performance and anxiety.

Hindmarch I and 1 other. Br J Clin Pharmacol, 1979. Cited by 23 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The effects of repeated nocturnal doses of clobazam, dipotassium chlorazepate and placebo on subjective ratings of sleep and early morning behaviour and objective measures of arousal, psychomotor performance and anxiety. Papers, record 41548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41548

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effects of repeated nocturnal doses of clobazam, dipotassium chlorazepate and placebo on subjective ratings of sleep and early morning behaviour and objective measures of arousal, psychomotor performance and anxiety.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
2.21
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hindmarch II
2Parrott ACA C

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
AnxietyMajor topic
BehaviorMajor topic
BenzodiazepinonesMajor topic
Clorazepate DipotassiumMajor topic
Motor SkillsMajor topic
SleepMajor topic
Adult
Arousal
Female
Humans
Male
Placebos

Source PubMed

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,037,258A sub-chronic study of the subjective quality of sleep and psychological measures of performance on the morning following night time medication with temazepam.Arzneimittelforschung1976https://conductscience.org/library/papers/1037258PubMed
21,106,446A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour.Arzneimittelforschung1975https://conductscience.org/library/papers/1106446PubMed
312,920A preliminary evaluation of the anxiolytic activity of clobazam.Curr Ther Res Clin Exp1977https://conductscience.org/library/papers/12920PubMed
416,635A repeated dose comparison of dichloralphenazone, flunitrazepam and amylobarbitone sodium on some aspects of sleep and early morning behaviour in normal subjects.Br J Clin Pharmacol1977https://conductscience.org/library/papers/16635PubMed
520,917Effect of the 1,5-benzodiazepines, clobazam and triflubazam, on sleep in man.Br J Clin Pharmacol1977https://conductscience.org/library/papers/20917PubMed
6239,907Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics.Int J Clin Pharmacol Biopharm1975https://conductscience.org/library/papers/239907PubMed
726,096Factor analysis of a sleep evaluation questionnaire.Psychol Med1978https://conductscience.org/library/papers/26096PubMed
835,205Pharmacokinetics of single and multiple doses of clobazam in humans.Br J Clin Pharmacol1979https://conductscience.org/library/papers/35205PubMed
935,211Some aspects of the effects of clobazam on human psychomotor performance.Br J Clin Pharmacol1979https://conductscience.org/library/papers/35211PubMed
1040,568
The effect of a sub-chronic administration of three dose levels of a 1,5-benzodiazepine derivative, clobazam, on subjective assessments of sleep and aspects of psychomotor performance the morning following night time medication.
Arzneimittelforschung1978https://conductscience.org/library/papers/40568PubMed
114,196,231Chlorazepate dipotassium in the treatment of anxiety associated with chronic gastrointestinal disease.Curr Ther Res Clin Exp1973https://conductscience.org/library/papers/4196231PubMed
124,198,306Clorazepate dipotassium, diazepam and placebo in chronic anxiety.Curr Ther Res Clin Exp1973https://conductscience.org/library/papers/4198306PubMed
134,629,306Clorazepate dipotassium in anxiety: a double-blind trial with diazepam controls.Curr Ther Res Clin Exp1972https://conductscience.org/library/papers/4629306PubMed
144,740,211Pharmacological and toxicological properties of clobazam (1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3H-1,5-benzodiazepine), a new psychotherapeutic agent.Arzneimittelforschung1973https://conductscience.org/library/papers/4740211PubMed
154,749,285Comparative psychophysiological and mood effects of diazepam and dipotassium clorazepate.Biol Psychiatry1973https://conductscience.org/library/papers/4749285PubMed
169,963Effect of N-desmethyldiazepam (nordiazepam) and a precursor, potassium clorazepate, on sleep in man.Br J Clin Pharmacol1976https://conductscience.org/library/papers/9963PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
7,370,640Hypnotics and hangover.Br Med J1980https://conductscience.org/library/papers/7370640PubMed
7,002,180Psychomotor function and psychoactive drugs.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7002180PubMed
6,805,019Sedative-hypnotics and human performance.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6805019PubMed
6,777,817The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6777817PubMed
6,407,054Effects of a 1,5-benzodiazepine derivative upon performance in an experimental stress situation.Psychopharmacology (Berl)1983https://conductscience.org/library/papers/6407054PubMed
6,129,143Nomifensine, clobazam and HOE 8476: effects on aspects of psychomotor performance and cognitive ability.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/6129143PubMed
6,107,238Clobazam: a review of its pharmacological properties and therapeutic use in anxiety.Drugs1980https://conductscience.org/library/papers/6107238PubMed
6,107,116The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6107116PubMed
2,689,183Effects of clobazam and clonazepam on saccadic eye movements and other parameters of psychomotor performance.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2689183PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41548

GET https://conductscience.org/api/papers/v1/41548/authors